House Democrats to investigate pricing policies of 12 major drug companies

Jan 14, 2019

As political pressure mounts to combat drug costs, a House Oversight Committee has announced that it will probe the pricing policies of 12 major companies.  

Led by Elijah Cummings (D-Md.), who leads the committee, said the goal of the investigation is to “determine why drug companies are increasing prices so dramatically, how drug companies are using the proceeds, and what steps can be taken to reduce prescription drug prices.”

The companies who have now received requests for pricing information include AstraZeneca, Teva, Celgene, Eli Lilly, Johnson & Johnson, Amgen, Pfizer, Novo Nordisk, Sanofi, AbbVie and Mallinckrodt. Some companies were asked to provide pricing information for one of their products, while others will be asked to disclose information on several drugs.  

Democrats took over the House at the beginning of the year, vowing to make prescription drug prices one of their top priorities. 

Read the full CNBC report.

Want to get news like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments